Literature DB >> 29752728

A retrospective study of dermatitis herpetiformis from an immunobullous disease clinic in north India.

Sanjeev Handa1, Garima Dabas1, Dipankar De1, Rahul Mahajan1, Debajyoti Chatterjee2, Uma N Saika2, Bishan D Radotra2.   

Abstract

BACKGROUND: Indian data on dermatitis herpetiformis (DH) is not available. The aim of this study was to investigate the demographic and clinicopathological characteristics of patients with DH and to study its association with other autoimmune diseases.
METHODS: All data were collected from case record forms of patients registered in immunobullous disease clinic of our institute. The diagnosis was based on characteristic clinical and immuno/histopathological features.
RESULTS: A total of 65 patients were included, which constituted 9.47% of the registered patients in the immunobullous disease clinic over 3.5 years. The male to female ratio was 1.4 : 1; the average age was 44.35 ± 15.52 years. Direct immunofluorescence showed granular IgA deposits at the papillary tips in 83.07% and basement membrane zone in 12.3% patients. Sixteen (24.1%) patients had associated celiac disease, and 15 (23.07%) patients had other autoimmune comorbidities such as hypothyroidism. Forty percent of patients on strict gluten-free diet achieved remission in 2 years, while 35.4% had frequent relapses as they continued gluten intake.
CONCLUSIONS: Dermatitis herpetiformis is not a rare disease in northern India as previously believed. The clinical, histological, and immunopathological characteristics of Indian DH patients are similar to those reported in Caucasian populations. The limitations of our study include an absence of genetic testing for HLA-DQ2 or DQ8, nonavailability of kits for detecting IgA specific for epidermal transglutaminase (IgA eTG), and short follow-up period.
© 2018 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29752728     DOI: 10.1111/ijd.14029

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Persistent Skin Symptoms after Diagnosis and on a Long-term Gluten-free Diet in Dermatitis Herpetiformis.

Authors:  Camilla Pasternack; Kaisa Hervonen; Eriika Mansikka; Timo Reunala; Pekka Collin; Katri Kaukinen; Teea Salmi
Journal:  Acta Derm Venereol       Date:  2021-09-22       Impact factor: 3.875

2.  Sex-differences in Gluten-free Dietary Adherence and Clinical Symptoms in Patients with Long-term Treated Dermatitis Herpetiformis.

Authors:  Camilla Pasternack; Kaisa Hervonen; Eriika Mansikka; Timo Reunala; Katri Kaukinen; Teea Salmi
Journal:  Acta Derm Venereol       Date:  2022-05-16       Impact factor: 3.875

3.  Anaemia in Dermatitis Herpetiformis: Prevalence and Associated Factors at Diagnosis and One-year Follow-up.

Authors:  Anna Alakoski; Camilla Pasternack; Timo Reunala; Katri Kaukinen; Heini Huhtala; Eriika Mansikka; Juha Jernman; Kaisa Hervonen; Teea Salmi
Journal:  Acta Derm Venereol       Date:  2021-04-29       Impact factor: 3.875

Review 4.  Dermatitis Herpetiformis: An Update on Diagnosis and Management.

Authors:  Timo Reunala; Kaisa Hervonen; Teea Salmi
Journal:  Am J Clin Dermatol       Date:  2021-05       Impact factor: 7.403

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.